Evaluation of the International Diffusion of the European Code Against Cancer Through Mobile Telephony
NCT ID: NCT05992792
Last Updated: 2023-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1990 participants
INTERVENTIONAL
2018-01-01
2022-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
NCT02549495
Disseminating Public Health Evidence to Support State Health Department Prevention of Cancer and Other Chronic Diseases
NCT01978054
mHealth App for Oral Hygiene and Cancer Awareness in Older Adults
NCT07275411
Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand
NCT05321992
Evaluation of an mHealth Intervention to Promote Participation in Breast Cancer Screening in Argentina
NCT06500936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The inclusion criteria were being 18 years or over, being entitled to health care benefits in SSPA, having a mobile phone, and being able to read messages on them. A sample of 1991 users from the User Database (BDU, in Spanish) of the SSPA, that in 2019 included more than 8.5 million users (REF), was used to randomly assign subjects to the different groups. The first randomization was performed according to the recruitment procedure (users registered or not in the SR platform) and the technology used to disseminate the messages (app or SMS). Group 1 (G1), subjects registered in the SR app service platform, and Group 2 (G2) subjects registered in the SR SMS service platform, were recruited through phone call. The rest of subjects needed to reach the target sample size were recruited from those included in the BDU database through a phone call. A maximum of eight attempts were done before considering no response. To be able to calculate participation rate (positive response rate + acceptance to participate), no replacement was performed.
For those not registered in the SR platform who accepted to participate in the study, a further distribution was done based on a discriminatory question: those users with internet connection in their mobile phone both through 3G/4G and Wi-Fi were allocated in Group 3 (G3) and encouraged to download the app to receive messages, and those without internet were allocated in Group 4 (G4) to receive messages by SMS. Informed consent to participate was requested for tehe investigators and the voluntary and anonymous nature of the participation was ensured. The simple randomisation to the different study groups was performed using the EPIDAT 4.0 programme. The second randomization was performed based on the messages' delivery frequency: frequency of 2 SMS or 2 app notifications ("push") per week, or frequency of 7 SMS or 7 app notifications per week.
Intervention After the second randomisation, an intervention was conducted for 4 weeks where participants were sent app push notifications or SMS messages via the SR platform. Each push notification or SMS message included a cancer prevention recommendation from the ECAC 4th edition (in Spanish) from the following list: "Don't smoke. Do not use any type of tobacco"; "Maintain a healthy weight"; "Exercise daily. Limit time spent sitting"; "Eat lots of whole grains, legumes, fruits and vegetables"; "Limit high-calorie foods (foods rich in sugar or fat) and avoid sugary drinks"; "Avoid processed meat; limit consumption of red meat and salt-rich foods"; "Limit alcohol consumption, although it is best for cancer prevention to avoid alcoholic beverages"; and the URL link to visit the Spanish version of the ECAC's website to consult additional information, through the mobile phone or other digital device. All messages were endorsed and signed by the Head of the Andalusian Regional Ministry of Health.
Data collection was conducted for the investigators at two time points: at baseline during the recruitment call, a pre-intervention survey was performed to gather basic socio-demographic and patterns of use of new technologies (e.g., type of mobile device, internet access from phone or computer, etc.); at the end of the intervention, from one week to one month after receiving the last message, a post-intervention survey was carried out by telephone to all participants.
Variables and categorization The sample was described for the investigators according to the following socio-demographic variables of the participants: sex, age, employment status, level of education, living alone or not, and province of residence. The mHealth-related variables included were the type of mobile phone, access to the Internet through the mobile phone or other digital device, permanent access to Internet data or only through Wi-Fi, ability to browse on the Internet and from which type of device, and willingness to receive messages in the future (acceptability of a future intervention). The survey questions were structured for the investigators to estimate intervention-related variables: the adoption of the innovation (number of messages read) for the participants, the fidelity to the mHealth implementation strategy (receiving and reading the number of messages expected), the preferred frequency and time to receive messages, willingness to seek further information (number of visits to the ECAC website), and perceived utility and understandability of the messages.
Statistical analysis The sample size was calculated for the investigators considering a confidence level of 95% (5% alpha error), a precision of 5% (width of the confidence interval), an expected proportion of 50% (maximum indeterminacy) in the main variables from the Conceptual Framework for Implementation Outcomes (adoption, fidelity, appropriateness, and acceptability), and a non-response rate of 5%.
Participation rate was considered for the investigators an outcome and therefore calculated as the rate of those who accepted participate in the study among all those who responded to the recruitment call. A descriptive analysis was performed for the investigators to assess homogeneity across groups by sociodemographic data by means of relative frequencies, using Chi-square test for categorical covariates and t-tests for continuous covariates, in the univariate analysis. The sample was also described at follow-up, according to socio-demographic data and patterns of mHealth use by messaging channel. The implementation research outcomes of adoption, fidelity, appropriateness, and acceptability, and willingness to visit the ECAC's website (coded as a form of adoption) for the participants, were calculated with relative frequencies by dissemination channel and intervention group. Finally, a multivariate logistic regression was conducted to characterize the participant socio-demographic characteristics associated with having read at least one message weekly. Crude and adjusted Odds Ratios (cOR and aOR) and its 95% confidence intervals (95% CI) were calculated. Significant association was defined with p≤0.05. STATA 17.0 and SPSS V.21.0. were used in the analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
App Salud Responde
Subjects register in the "Salud Responde" (SR) app services de platform
App message
Participantes push App message cancer prevention from the recomendations ECAC. 2 SMS notifications (push) per week or frequency of app notifications per week.
SMS Salud Responde
Subjects register in SR SMS services platform
SMS message
Participants push SMS message cancer prevention from the ECAC. Second randomization for received 2 notifications (push) per week or frequency of 7 SMS notifications per week.
Internet
Subjects users with internet in their mobile phone
Internet
Internet connection in their mobile phone and WI-Fi. Participants push message cancer prevention from the recomendations ECAC. Second randomization for received 2 notifications (push) per week or frequency of 7 SMS notifications per week.
Whitout internet
Subjects whitout internet to recibe message by SMS
Whithout internet
Second randomization for received 2 notifications (push) per week or frequency of 7 SMS notifications per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
App message
Participantes push App message cancer prevention from the recomendations ECAC. 2 SMS notifications (push) per week or frequency of app notifications per week.
SMS message
Participants push SMS message cancer prevention from the ECAC. Second randomization for received 2 notifications (push) per week or frequency of 7 SMS notifications per week.
Internet
Internet connection in their mobile phone and WI-Fi. Participants push message cancer prevention from the recomendations ECAC. Second randomization for received 2 notifications (push) per week or frequency of 7 SMS notifications per week.
Whithout internet
Second randomization for received 2 notifications (push) per week or frequency of 7 SMS notifications per week.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Agency for Research on Cancer
OTHER
Hospital Universitario Reina Sofia de Cordoba
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luis A Perula
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolina Espina
Role: PRINCIPAL_INVESTIGATOR
World Health Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cordoba
Córdoba, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Espina C, Feliu A, Gonzalez Vingut A, Liddle T, Jimenez-Garcia C, Olaya-Caro I, Perula-De-Torres LA. Population-Based Cancer Prevention Education Intervention Through mHealth: A Randomized Controlled Trial. J Med Syst. 2024 Jan 9;48(1):9. doi: 10.1007/s10916-023-02026-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP-0176-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.